Xenon Pharmaceuticals to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference – GlobeNewswire

0
9

BURNABY, British Columbia, Aug. 10, 2021 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced its participation in one-on-one investor meetings as well as a virtual panel discussion at the 12th Annual Wedbush PacGrow Healthcare Conference.

Panel Topic: “Got My Mind Set On You – Advancing Novel Epilepsy Targets”
   
Date: Wednesday, August 11, 2021
   
Time: 11:30 am – 12 pm Eastern Time
   
Panelist: Dr. Simon Pimstone, Executive Chair of the Board

Additional details along with a link to the live webcast can be found on the “Investors” section of Xenon’s website at http://investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event for 30 days. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Maria McClean
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here